“…1, Table 2). Three studies were excluded because EML was applied directly to all the patients of EST group but none of ESBD group, [29][30][31] which could not accurately reflect the usage of EML. One study was excluded because patients with coagulopathy were enrolled.…”
Section: Resultsmentioning
confidence: 99%
“…We also strictly screened for less-biased studies by excluding studies enrolling patients with coagulopathy and those not using EML as a remedy but a routine. 29,30,32 Our meta-analysis has several limitations. First, there were limited studies enrolled, which might decrease the robustness of the analysis and mask the presence of publication bias.…”
Section: Discussionmentioning
confidence: 99%
“…One of the strengths of our review compared with this review is that we applied a statistical method to separately combine the results of RCTs and nonrandomized studies, quality of which had been comprehensively evaluated. We also strictly screened for less‐biased studies by excluding studies enrolling patients with coagulopathy and those not using EML as a remedy but a routine …”
ESBD is feasible for the treatment of choledocholithiasis without increased risk of complications, causing less bleeding. However, it warrants more clinical trials to compare the efficacy and safety of ESBD and EST.
“…1, Table 2). Three studies were excluded because EML was applied directly to all the patients of EST group but none of ESBD group, [29][30][31] which could not accurately reflect the usage of EML. One study was excluded because patients with coagulopathy were enrolled.…”
Section: Resultsmentioning
confidence: 99%
“…We also strictly screened for less-biased studies by excluding studies enrolling patients with coagulopathy and those not using EML as a remedy but a routine. 29,30,32 Our meta-analysis has several limitations. First, there were limited studies enrolled, which might decrease the robustness of the analysis and mask the presence of publication bias.…”
Section: Discussionmentioning
confidence: 99%
“…One of the strengths of our review compared with this review is that we applied a statistical method to separately combine the results of RCTs and nonrandomized studies, quality of which had been comprehensively evaluated. We also strictly screened for less‐biased studies by excluding studies enrolling patients with coagulopathy and those not using EML as a remedy but a routine …”
ESBD is feasible for the treatment of choledocholithiasis without increased risk of complications, causing less bleeding. However, it warrants more clinical trials to compare the efficacy and safety of ESBD and EST.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.